Literature DB >> 7629299

Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.

T Mainou-Fowler1, J A Copplestone, A G Prentice.   

Abstract

AIMS: To investigate the effects of interleukin (IL) 1, 2, 4, and 5 on the proliferation and survival of peripheral blood B cells from patients with B chronic lymphocytic leukaemia (B-CLL) and compare them with the effects on normal peripheral blood B cells.
METHODS: The proliferation and survival of pokeweed mitogen (PWM) activated B cells from B-CLL (n = 12) and normal peripheral blood (n = 5) were studied in vitro in response to IL-1, IL-2 IL-4, and IL-5. Survival of cells in cultures with or without added interleukins was studied by microscopic examination of cells and DNA agarose gel electrophoresis.
RESULTS: Proliferation was observed in both B-CLL and normal peripheral blood cells on culture with IL-2 alone and also in some, but not all, B-CLL and normal peripheral blood cells with IL-1 and IL-4. However, there was greater variability in B-CLL cell responses than in normal peripheral blood cells. Il-5 did not affect normal peripheral blood cell proliferation but it increased proliferation in two B-CLL cases. Synergistic effects of these cytokines were not detected. IL-4 inhibited normal peripheral blood and B-CLL cell proliferation after the addition of IL-2. Inhibition of B-CLL cell responses to IL-2 was also observed with IL-5 and Il-1. Survival of B-CLL cells in cultures was enhanced with IL-4 not by an increase in proliferation but by reduced apoptosis. No such effect was seen in normal peripheral blood cells. IL-2 had a less noticeable antiapoptotic effect; IL-5 enhanced apoptosis in B-CLL cells.
CONCLUSIONS: B-CLL and normal peripheral blood cells proliferated equally well in response to IL-2. IL-4 had a much lower effect on B-CLL cell proliferation, but had noticeable antiapoptotic activity. IL-5 enhanced cell death by apoptosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629299      PMCID: PMC502630          DOI: 10.1136/jcp.48.5.482

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

Review 1.  Growth and differentiation factors for B and T cells.

Authors:  M Hansson
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

Review 2.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

3.  Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal.

Authors:  S Karray; H Merle-Béral; A Vazquez; J P Gerard; P Debre; P Galanaud
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

4.  IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells.

Authors:  S Karray; A Dautry-Varsat; M Tsudo; H Merle-Beral; P Debre; P Galanaud
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

5.  The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors.

Authors:  I Touw; L Dorssers; B Löwenberg
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

6.  Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.

Authors:  C Hivroz; C Grillot-Courvalin; J C Brouet; M Seligmann
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

7.  Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.

Authors:  R T Perri
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

8.  Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.

Authors:  P Panayiotidis; K Ganeshaguru; S A Jabbar; A V Hoffbrand
Journal:  Br J Haematol       Date:  1993-11       Impact factor: 6.998

9.  Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor.

Authors:  S L Swain; R W Dutton
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

10.  Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.

Authors:  M Dancescu; M Rubio-Trujillo; G Biron; D Bron; G Delespesse; M Sarfati
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  3 in total

1.  The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.

Authors:  Mohammad Luqman; Sha Klabunde; Karen Lin; Georgios V Georgakis; Anu Cherukuri; Jocelyn Holash; Cheryl Goldbeck; Xiaomei Xu; Edward E Kadel; Sang Hoon Lee; Sharon Lea Aukerman; Bahija Jallal; Natasha Aziz; Wen-Kai Weng; William Wierda; Susan O'Brien; Anas Younes
Journal:  Blood       Date:  2008-05-22       Impact factor: 22.113

2.  Effects of interleukins on the proliferation and survival of chronic lymphocytic leukaemia cells.

Authors:  M H Gilleece; C M Heyworth; N G Testa; T M Dexter
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

3.  Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.

Authors:  T Robak; A Wierzbowska; M Błasińska-Morawiec; A Korycka; J Z Błoński
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.